[1]
L. F. C. de Almeida, “Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis”, MAST, vol. 35, no. suppl.1, Feb. 2026.